HomeExecutive & Strategy (CSO & CEO)Evaluating Critical Asset Safeguards for Pharmaceutical Manufacturers

Evaluating Critical Asset Safeguards for Pharmaceutical Manufacturers



Related stories

Transforming processes in the new way of finance

The role of the finance team and CFO are...

Less stress, more success: Leverage AI for happier agents

AI solutions are currently transforming the contact center industry....

Harnessing the Potential of AI

Artificial Intelligence (AI) is revolutionizing the way businesses operate...

Navigating the Security Testing Landscape

Learn what creates a comprehensive security testing strategy Are you...

See why it’s the right time to invest in robotic solutions

Read the IDC infographic, which offers insights on the...

Pharmaceutical and Biotechnology companies create products that generate billions of dollars in annual sales. As product demand and manufacturing outputs increase for these products, so do the demands for trouble free manufacturing equipment, performance and reliability requirements. One central issue for these companies’ supply chains is the lack of an effective risk management process for readily identifying the potential for equipment performance issues or breakdowns. The absence of such a process creates a major imperative for these companies

GenesisSolutions, the Asset Management service line of ABS Group, launched an initiative to address risk and equipment reliability issues that may affect the products manufactured by a global pharmaceutical company. A risk management solution was developed to standardize an approach to addressing specific products across the company’s multiple facilities.

Download Whitepaper


By sharing your work email as above, you agree that smart-leaders-buzz can access this download and use information, in accordance of our Privacy Policy.


- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories